[{"address1": "321 Harrison Avenue", "address2": "Suite 900", "city": "Boston", "state": "MA", "zip": "02118", "country": "United States", "phone": "617 949 2643", "website": "https://www.monterosatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops MRT-2359, an orally bioavailable molecular glue degrader targeting the translation termination factor protein GSPT1 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of systemic and central nervous system autoimmune diseases; and MRT-8102 for the treatment of IL-1?/NLRP3 driven inflammatory diseases. It also develops CDK2 to treat ovarian, uterine, and breast cancers. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 133, "companyOfficers": [{"maxAge": 1, "name": "Dr. Markus  Warmuth M.D.", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 924600, "exercisedValue": 0, "unexercisedValue": 2041632}, {"maxAge": 1, "name": "Dr. Filip  Janku M.D., Ph.D.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 713200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Champoux", "title": "Chief Operating Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John C. Castle Ph.D.", "age": 53, "title": "Chief Data & Information Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sharon  Townson Ph.D.", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Funderburk", "title": "Senior VP and Head of IR & Strategic Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Nickson J.D., Ph.D.", "age": 45, "title": "Chief Business & Legal Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Magnus  Walter DPHIL", "title": "Senior Vice President of Drug Discovery", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Dunn", "age": 58, "title": "Vice President & Corporate Controller", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.29, "open": 6.35, "dayLow": 6.09, "dayHigh": 6.665, "regularMarketPreviousClose": 6.29, "regularMarketOpen": 6.35, "regularMarketDayLow": 6.09, "regularMarketDayHigh": 6.665, "payoutRatio": 0.0, "beta": 1.496, "forwardPE": -4.2599998, "volume": 813580, "regularMarketVolume": 813580, "averageVolume": 954103, "averageVolume10days": 577200, "averageDailyVolume10Day": 577200, "bid": 6.39, "ask": 7.87, "bidSize": 2, "askSize": 2, "marketCap": 392580512, "fiftyTwoWeekLow": 3.21, "fiftyTwoWeekHigh": 12.4, "priceToSalesTrailing12Months": 26.215727, "fiftyDayAverage": 6.2934, "twoHundredDayAverage": 5.925825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 194088784, "profitMargins": 0.0, "floatShares": 33985231, "sharesOutstanding": 61436700, "sharesShort": 8029011, "sharesShortPriorMonth": 8755986, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.13069999, "heldPercentInsiders": 0.0070499997, "heldPercentInstitutions": 1.02416, "shortRatio": 12.66, "shortPercentOfFloat": 0.2387, "impliedSharesOutstanding": 61436700, "bookValue": 3.347, "priceToBook": 1.9091724, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -119389000, "trailingEps": -1.78, "forwardEps": -1.5, "enterpriseToRevenue": 12.961, "enterpriseToEbitda": -1.603, "52WeekChange": 0.011254072, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 6.39, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 16.0, "targetMedianPrice": 15.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 242186000, "totalCashPerShare": 3.942, "ebitda": -121073000, "totalDebt": 43698000, "quickRatio": 5.83, "currentRatio": 6.033, "totalRevenue": 14975000, "debtToEquity": 21.269, "revenuePerShare": 0.221, "returnOnAssets": -0.28425, "returnOnEquity": -0.61228, "grossProfits": 16777000, "freeCashflow": -47188876, "operatingCashflow": -57292000, "grossMargins": 1.12033, "ebitdaMargins": 0.0, "operatingMargins": -2.87836, "financialCurrency": "USD", "symbol": "GLUE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.5898237, "regularMarketPrice": 6.39, "corporateActions": [], "postMarketTime": 1741389088, "regularMarketTime": 1741381202, "exchange": "NMS", "messageBoardId": "finmb_690261281", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Monte Rosa Therapeutics, Inc.", "marketState": "CLOSED", "shortName": "Monte Rosa Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624541400000, "postMarketChangePercent": 4.06886, "postMarketPrice": 6.65, "postMarketChange": 0.26, "regularMarketChange": 0.099999905, "regularMarketDayRange": "6.09 - 6.665", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 954103, "fiftyTwoWeekLowChange": 3.1799998, "fiftyTwoWeekLowChangePercent": 0.9906541, "fiftyTwoWeekRange": "3.21 - 12.4", "fiftyTwoWeekHighChange": -6.0099998, "fiftyTwoWeekHighChangePercent": -0.4846774, "fiftyTwoWeekChangePercent": 1.1254072, "epsTrailingTwelveMonths": -1.78, "epsForward": -1.5, "epsCurrentYear": -1.11356, "priceEpsCurrentYear": -5.738353, "fiftyDayAverageChange": 0.096600056, "fiftyDayAverageChangePercent": 0.015349423, "twoHundredDayAverageChange": 0.46417475, "twoHundredDayAverageChangePercent": 0.07833082, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-24", "cryptoTradeable": false, "displayName": "Monte Rosa Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]